|
Investigation summary: manufacturing location: (b)(4), manufacturing date: 30-mar-2000, part number: 329.769, bending template 6 x 23 holes f/angled reconstruction plate, lot number: 4066264 (non-sterile), lot quantity: 27.Work order traveler met all inspection acceptance criteria.Inspection sheet met all inspection acceptance criteria.Packaging label log was reviewed and determined to be conforming.This lot met all dimensional, visual, sterility and packaging criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.Visual inspection: the bending template 6 x 23 holes f/angled reconstruction plates (p/n 329.769) was received at customer quality (cq), and it was observed that distal end of the plate was broken off.The broken part was not returned.The complaint of broken (2+ pieces) is confirmed.Device failure/ defect identified? yes.Dimensional inspection: the minor diameter 4.75 +/- 0.20mm of the plate got measured.Minor diameter: 4.75 +/- 0.20mm, caliper: ca 215p, measured diameter = 4.80 mm.Conclusion: the measuring result does show conformity.The major diameter 8 +/- 0.2mm of the plate got measured.Major diameter: 8 +/- 0.2mm, caliper: ca 215p, measured diameter = 7.99 mm.Conclusion: the measuring result does show conformity.Document/ specification review: the respective drawing(s) was reviewed this lot met all dimensional, visual and packaging criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.Complaint confirmed? yes.Investigation conclusion: a definitive assignable root cause for the post manufacturing damage could not be determined based on the provided information.This complaint is confirmed however no product design issues or manufacturing discrepancies that would contribute to the reported complaint condition were identified during this investigation.No new, unique or different patient harms were identified because of this evaluation.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post market safety surveillance activities.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H11 corrected data: h4 (device manufacture date).Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|